Content area

|
|

Transoral robotkirurgi til behandling af hoved-hals-kræft

Forfatter(e)
Hani Ibrahim Channir, Asher Lou Isenberg, Niclas Rubek, Anne Fog Lomholt, Susanne Irene Scott, Jesper Filtenborg Tvedskov,
Birgitte Wittenborg Charabi & Christian von Buchwald Øre-næse-halskirurgisk og Audiologisk Klinik, Rigshospitalet

Ugeskr Læger 2018;180:V05180341
Reference: 
Ugeskr Læger 2018;180:V05180341
Sidetal: 

Hani Ibrahim Channir, Asher Lou Isenberg, Niclas Rubek, Anne Fog Lomholt, Susanne Irene Scott, Jesper Filtenborg Tvedskov, Birgitte Wittenborg Charabi & Christian von Buchwald:

Transoral robotic surgery for head and neck cancer

Ugeskr Læger 2018;180:V05180341

Oropharyngeal squamous cell carcinoma (OPSCC) induced by human papillomavirus (HPV) is highly prevalent in the western part of the world. Patients with HPV-induced OPSCC are often younger and have a much better prognosis than patients with HPV-negative OPSCC. The newly introduced transoral robotic surgery offers the ability to perform en bloc tumour resection with good margin control. It may be an alternative to the traditional radiation therapy for early-stage OPSCC. A Danish randomised clinical trial is now aiming at comparing these two treatments with a focus on long-term functional outcomes.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Lars Erik Larsen | 19/02
3 kommentarer
af Svend Ovesen | 18/02
1 Kommentar
af Peter Gammelgaard Petersen | 18/02
1 Kommentar
af Steen Frobenius | 17/02
2 kommentarer
af Lawkesh Vimal Hurry | 16/02
3 kommentarer